ClariVest Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-25,900
Closed -$656K 722
2016
Q4
$656K Sell
25,900
-28,360
-52% -$629K 0.02% 382
2016
Q3
$1.08M Sell
54,260
-15,740
-22% -$275K 0.03% 297
2016
Q2
$1M Sell
70,000
-3,960
-5% -$60.5K 0.03% 292
2016
Q1
$1.15M Buy
73,960
+31,844
+76% +$457K 0.03% 268
2015
Q4
$727K Buy
+42,116
New +$609K 0.02% 319

Other funds holding LMAT

ClariVest Asset Management's LMAT Position: Q1 2017 in Review

ClariVest Asset Management sold out of LeMaitre Vascular (LMAT) in Q1 2017, closing a stake of 25,900 shares — an estimated $656K sold.

ClariVest Asset Management first reported a position in LMAT in Q4 2015 and held it in 5 quarters. The position peaked at $1.15M in Q1 2016. 114 funds tracked by Wall St. Rank hold LMAT as of Q1 2017.

  • ClariVest Asset Management reported no remaining LeMaitre Vascular position as of Q1 2017 after selling out during the quarter.
  • ClariVest Asset Management sold 25,900 LeMaitre Vascular shares in Q1 2017, an estimated $656K.
  • ClariVest Asset Management first reported a position in LeMaitre Vascular in Q4 2015 and held it in 5 quarters.
  • ClariVest Asset Management's LeMaitre Vascular position peaked at $1.15M in Q1 2016.
  • 114 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2017.

Based on ClariVest Asset Management's 13F filing for Q1 2017, filed 11 May 2017.